Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Mylan Launches Generic Version of Famvir® Tablets

April 20, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, April 20, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Famciclovir Tablets, 125 mg, 250 mg and 500 mg, the generic version of Novartis' Famvir® Tablets, a treatment for herpes.   Famciclovir Tablets had...

Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis

April 19, 2011 8:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 19, 2011 /- Amira Pharmaceuticals, Inc. announced today that AM152, the company's lead LPA1 antagonist, has been granted an orphan drug designation by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis. Commonly referred to as IPF,...

Southern Home Medical Equipment Launches Respi-Care Respiratory Therapy Program

April 19, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

LYMAN, S.C., April 19, 2011 /- Southern Home Medical Equipment, Inc. (PINKSHEETS: SHOM), a Holding Company providing healthcare services, healthcare professionals and equipment to medical institutions, announced today that in response to the growing demand for specialized solutions for...


GlideScope Video Laryngoscope from Verathon Medical Canada Celebrates 10th Anniversary of Video Laryngoscopy and Improving Patient Care

April 18, 2011 11:34 am | by Bio-Medicine.Org | News | Comments

BOTHELL, Wash., April 18, 2011 /- The GlideScope® video laryngoscope, invented by Canadian vascular surgeon Dr. Jack Pacey and manufactured in Vancouver, B.C., is celebrating its tenth anniversary in 2011.  A celebration will be held on April 21st at the company's new...

Study Finds Exergen Temporal Artery Thermometry Accurate on Newborns

April 18, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

WATERTOWN, Mass., April 18, 2011 /- Measuring the body temperatures of newborns with temporal artery thermometry (forehead scanning) provides readings comparable to results obtained by axillary (under arm) thermometry, the clinically recommended method for this patient population, but...

Bedford Laboratoriesâ„¢ to Begin Shipping Topotecan Hydrochloride for Injection, 4mg SD Vial

April 18, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Ohio,  April 18, 2011 /- Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., is pleased to announce the addition of Topotecan Hydrochloride for Injection, 4 mg (base)/vial to its diverse portfolio.  Topotecan is AP Bioequivalent to the reference...

La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders

April 17, 2011 10:33 am | by EurekAlert | News | Comments

(La Jolla Institute for Allergy and Immunology) Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising...

ERT Reports First Quarter 2011 Operating Results on May 2, 2011

April 15, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, April 15, 2011 /- ERT (Nasdaq: ERES ) announced today that it will release its operating results for the first quarter 2011 Monday, May 2, after the market closes. After the release, the Company will host a conference call at 5:00 PM ET that day. For the conference call,...


Safety of stored blood among chief concerns for transfusion medicine community

April 14, 2011 9:33 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) In light of recent studies that suggest the use of stored blood during transfusions may cause adverse effects in patients, the National Heart, Lung, and Blood Institute funded a number of research projects to examine the safety of transfusing older red cells and the...

Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting

April 14, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 14, 2011 /- New results from the largest multicenter clinical trial for heart transplant patients will be released this week at the International Society for Heart & Lung Transplantation (ISHLT) 31st Annual Meeting and Scientific Sessions in San Diego.  Results...

ERT Awarded over $10 Million of ePRO Business from Major Pharma – Increasing its Position as a Leading ePRO Provider

April 14, 2011 7:33 am | by RealWire | News | Comments

PHILADELPHIA, PA - 14 April 2011 ERT, a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, announced today that it was awarded three new contracts with top tier pharmaceutical companies, totaling over...

Mpex Pharmaceuticals, Inc. to be Acquired by Axcan

April 14, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 14, 2011 /- Mpex Pharmaceuticals, Inc. announced today that Axcan and Mpex have entered into agreements pursuant to which Axcan will acquire all of the outstanding shares of Mpex and its lead product candidate, Aeroquin™.  A proprietary aerosol formulation of...

Congress Must Maintain Commitment to Advanced Biofuels and Renewable Fuel Standard, BIO Says

April 14, 2011 5:34 am | by Biotechnology Industry Organization | News | Comments

WASHINGTON, D.C. (Wednesday, April 13, 2011) - The Renewable Fuel Standard provides the market and regulatory certainty necessary to drive private investment and maintain progress in research and development of advanced biofuels, the Biotechnology Industry Organization (BIO) said today in...


Tissue Engineering Shows Promise to Revolutionize Transplant Medicine

April 13, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 13, 2011 /- The engineering of replacement tissue shows promise to dramatically impact the treatment of patients with end stage heart failure.  While the field is still in early stages, researchers will discuss the potential for a revolutionary change in medicine at...

Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations

April 13, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

CENTENNIAL, Colo., April 13, 2011 /- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced the hire of Angela Horacek...

MSA Schedules First Quarter Earnings Webcast

April 12, 2011 11:35 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, April 12, 2011 /- MSA (NYSE: MSA ), the global leader in the development, manufacture and supply of products that protect people's health and safety, announced today that it will broadcast a first quarter 2011 earnings conference call live via the Internet on Thursday, April...

Montana Medical Equipment Providers Back New Congressional Bill to Repeal Flawed Medicare Bidding Program

April 12, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

HELENA, Mont., April 12, 2011 /PRNewswire-USNewswire/ -- The association representing Montana's providers of home medical equipment and services supports a new, bipartisan bill in Congress to repeal the controversial Medicare "competitive" bidding program for home medical equipment and...

Pediatric-specific research needed to reduce health care-associated infections among children

April 12, 2011 8:35 am | by EurekAlert | News | Comments

(JAMA and Archives Journals) There are differences between adult and pediatric patients regarding the appropriate treatment and prevention efforts for health-care associated infections, highlighting a need for pediatric-specific quality measures to guide infection prevention and treatment...

MAP Pharmaceuticals to Present Data From LEVADEX® Pharmacokinetics and Pharmacodynamics Safety Studies at the 63rd Annual Meeting of the American Academy of Neurology

April 12, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., April 12, 2011 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that the Company will present new data from two safety studies of LEVADEX® orally inhaled migraine drug.  The data will be presented at the 63rd Annual Meeting of the American...

HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting

April 12, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

FRAMINGHAM, Mass. and SYDNEY, April 12, 2011 /- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the...

Ikaria® Launches Next-Generation Drug-Delivery System

April 11, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

CLINTON, N.J., April 11, 2011 /- Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients in the hospital and ICU settings, today announced the introduction of its next-generation drug-delivery system, the INOMAX...

PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)

April 11, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., April 11, 2011 /- PharMEDium Healthcare Corporation has become an Industry Supporter of the American Society of Anesthesiologists (ASA), as a part of a new Corporate Supporter program available to pharmaceutical, medical device and practice management companies. David...

New review suggests drinking 100 percent fruit juice may offer disease-fighting benefits

April 10, 2011 9:33 pm | by EurekAlert | News | Comments

(Kellen Communications) Highlights from a new report summarizing recent research on the potential benefits of 100 percent fruit juice suggest a positive association between intake of 100 percent juice and reduced risk for several chronic diseases, including cancer, markers for...

Flu helps spread pneumonia

April 10, 2011 5:32 pm | by EurekAlert | News | Comments

(Society for General Microbiology) Bacteria that cause pneumonia and meningitis are only able to spread when individuals are infected with flu, says a scientist reporting at the Society for General Microbiology's Spring Conference in Harrogate. The work could have implications for the...

Dr. Larissa Shimoda to discuss mechanisms of hypoxic pulmonary hypertension

April 10, 2011 3:33 pm | by EurekAlert | News | Comments

(American Physiological Society) When muscles and organs are deprived of an adequate supply of oxygen, the body's usual responses include increased circulation and slight drop in blood pressure in the blood vessels serving the affected tissue. However, the blood vessels in the lungs react...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.